Societies

Mark your calendars for our upcoming virtual Grand Rounds to explore the use of Precision Medicine through the TAPUR Study – ASCO

Photo taken from ASCO/LinkedIn

Apr 11, 2024, 17:43

Mark your calendars for our upcoming virtual Grand Rounds to explore the use of Precision Medicine through the TAPUR Study – ASCO

American Society of Clinical Oncology (ASCO) shared a post LinkedIn:

“Mark your calendars for our upcoming virtual Grand Rounds to explore the use of Precision Medicine through the TAPUR Study. The TAPUR Study is an ongoing Clinical Trial conducted by ASCO that examines the potential of using targeted therapies outside of their approved use to benefit patients with later-stage cancer, leading to increased options for personalised therapies.
When: Monday, May 6, at 2:00 PM ET
Where: Online
Who: Open to all members of the oncology community

Featured speakers include:

Richard Schilsky, TAPUR Study Principal Investigator.
Jens Rueter, Medical Director of the Maine Cancer Genomics Initiative.
Janet Freeman-Daily, Lung cancer patient and advocate; President of The ROS1ders.”

Additional information.
Source: ASCO/LinkedIn

American Society of Clinical Oncology ASCO cancer Janet Freeman-Daily Jens Rueter Lung cancer OncoDaily Oncology patient Precision Medicine Richard Schilsky TAPUR The ROS1ders

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage